Estradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptoms

Menopause : the Journal of the North American Menopause Society
James A Simon, ESTRASORB Study Group

Abstract

To assess the efficacy and safety of topical micellar nanoparticle estradiol emulsion (MNPEE; Estrasorb; Novavax, Inc., Malvern, PA) in postmenopausal women with moderate to severe vasomotor symptoms. A multicenter, randomized, double-blind, placebo-controlled study was conducted in 200 postmenopausal women with seven or more moderate to severe hot flushes per day. The study consisted of a 3-week screening period followed by a 1-week placebo emulsion run-in period and a 12-week active or placebo treatment period. Women were randomized (1:1) to receive MNPEE (3.45 g daily dose of emulsion containing 8.6 mg estradiol) or matching placebo emulsion. The primary efficacy variable was the change from baseline in the frequency of moderate and severe hot flushes at weeks 4 and 12. Adverse events were monitored throughout the trial. Topical micellar nanoparticle estradiol emulsion was statistically significantly superior to placebo emulsion in reducing the mean frequency of moderate to severe vasomotor symptoms by week 3 (P = 0.003), with superiority to placebo maintained from weeks 4 to 12 (P < 0.001). At week 12 (peak benefit), MNPEE reduced mean daily frequency of hot flush count by 11.1 (P < 0.001 vs placebo). MNPEE significantly re...Continue Reading

References

Jul 1, 1971·Steroids·C H Wu, L E Lundy
Feb 1, 1995·American Journal of Obstetrics and Gynecology·S P SuhonenP Lähteenmäki
Apr 3, 1999·Annals of Internal Medicine·N L KeatingJ Z Ayanian
Sep 19, 2000·Menopause : the Journal of the North American Menopause Society·M Notelovitz, J H Mattox
Aug 31, 2001·Menopause : the Journal of the North American Menopause Society·J KayserA Pressman
Oct 2, 2003·JAMA : the Journal of the American Medical Association·Jane A CauleyUNKNOWN Women's Health Initiative Investigators
Nov 25, 2003·Menopause : the Journal of the North American Menopause Society·David F Archer, UNKNOWN EstroGel Study Group
Feb 6, 2004·Annals of Internal Medicine·Jennifer S HaasKarla Kerlikowske
Apr 8, 2004·JAMA : the Journal of the American Medical Association·Heidi D Nelson
Apr 8, 2004·JAMA : the Journal of the American Medical Association·Heidi D Nelson
Oct 2, 2004·Obstetrics and Gynecology·UNKNOWN American College of Obstetricians and Gynecologists Women's Health Care Physicians

❮ Previous
Next ❯

Citations

Dec 30, 2011·Menopause : the Journal of the North American Menopause Society·Tomas L GrieblingPeter G Smith
Nov 19, 2009·Drug Design, Development and Therapy·Nathan W KopperDaniel J Thompson
Jul 1, 2006·Women's Health·Deborah R Kim, Hadine Joffe
Mar 13, 2013·Nanomedicine·Catherine A SchützUNKNOWN NanoImpactNet Consortium
May 28, 2008·Pharmacotherapy·Maida B Taylor, Maria J Gutierrez
Feb 7, 2018·Nanotechnology Reviews·Parham Sahandi ZangabadMichael R Hamblin
Nov 20, 2018·Nanomedicine·Fatemeh FarjadianMichael R Hamblin
Jan 28, 2020·Journal of Drug Targeting·Shaheen SultanaNasir Ali Siddiqui
Jun 8, 2017·Journal of Applied Toxicology : JAT·Hong SuMin Ding
Oct 18, 2019·BJOG : an International Journal of Obstetrics and Gynaecology·S IliodromitiM Hickey
Dec 5, 2019·Expert Opinion on Drug Delivery·Julia Files, Juliana M Kling
Oct 26, 2018·International Journal of Molecular Sciences·Ding-Ping BaiXi-Feng Zhang
Oct 16, 2014·British Journal of Clinical Pharmacology·Lujin LiQingshan Zheng
Jan 26, 2017·Journal of Menopausal Medicine·Fatemeh AbdiNariman Mosaffa
Nov 28, 2017·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Roxana JijieSabine Szunerits
Aug 2, 2016·The Cochrane Database of Systematic Reviews·Ana Marcia I S GaudardMaria R Torloni
Dec 29, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Vedant GadekarRakesh K Tekade
Feb 14, 2012·Maturitas·Pilar Valenzuela, James A Simon
May 30, 2012·Nanomedicine : Nanotechnology, Biology, and Medicine·Pilar Valenzuela, James A Simon
Oct 6, 2012·Advanced Drug Delivery Reviews·Theresa M Allen, Pieter R Cullis
Jan 28, 2022·Menopause : the Journal of the North American Menopause Society·Kentaro MiyazakiMamoru Narukawa

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.